Zura Bio Limited (ZURA) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -18.92M | -22.28M | -15.44M | -16.03M | -11.06M | -10.82M | -5.65M | -6.62M | -4.98M | -4.05M | -2.57M | -5.17M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -71.05% | -105.82% | -173.2% | -142.25% | -122.06% | -167.06% | -119.88% | -27.91% | -52.96% | - | -862% | -993.95% |
| Net Income | -24.22M | -17.18M | -20.04M | -15.99M | -17.44M | -11.29M | -20.7M | -12.67M | -7.75M | -8.47M | -8.27M | -34.02M |
| Depreciation & Amortization | 16K | 15K | 14K | 11K | 9K | 5K | 3K | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 5.01M | 2.58M | 0 | 3.73M | 3.64M | 2.82M | 8.65M | 2.93M | 2.41M | 2.39M | 2.58M | 2.32M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 5K | -4.99M | 4.38M | 43K | 24K | -2.33M | 3.86M | 3.1M | 583K | -983K | 288K | 27.5M |
| Working Capital Changes | 271K | -2.71M | 197K | -3.82M | 2.7M | -25K | 2.54M | 19K | -227K | 3.01M | 2.83M | -969K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.22M | -3.08M | 1.79M | -2.45M | 1.58M | 2.17M | 2.26M | 394K | 0 | 3.31M | 3.04M | -861K |
| Cash from Investing | -13K | -17K | -32K | -15K | -49K | -45K | -13K | -10K | -5.01M | 0 | -2.25M | -5.75M |
| Capital Expenditures | -13K | -17K | -32K | -15K | -49K | 4.96M | -13K | -10K | -7K | 0 | -2.25M | -5.75M |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | -5M | 0 | 0 | -5M | 0 | 0 | 0 |
| Cash from Financing | 135.12M | -7.32M | 3K | -34K | 5.18M | -854K | 5.44M | 105.25M | 0 | 0 | -4.12M | 79.76M |
| Debt Issued (Net) | 0 | 0 | -90K | 0 | 90K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 135.12M | 17K | 93K | 0 | 5.09M | -60.76M | 5.53M | 55.22M | 0 | 0 | -4.12M | 63.85M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -7.33M | 0 | -34K | 0 | 59.9M | -90K | 50.03M | 0 | 0 | 0 | 15.92M |
| Net Change in Cash | 116.19M | -29.61M | -15.47M | -16.08M | -5.93M | -11.72M | -222K | 98.63M | -9.99M | -4.05M | -8.94M | 68.84M |
| Free Cash Flow | -18.94M | -22.3M | -15.48M | -16.05M | -11.11M | -10.87M | -5.67M | -6.63M | -9.99M | -4.05M | -4.82M | -10.92M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -70.41% | -105.12% | -173.14% | -142.12% | -11.24% | -168.17% | -17.53% | 39.33% | -206.69% | - | -1703.86% | -2209.89% |
| FCF per Share | -0.17 | -0.24 | -0.16 | -0.17 | -0.17 | -0.17 | -0.06 | -0.09 | -0.21 | -0.09 | -0.10 | -0.32 |
| FCF Conversion (FCF/Net Income) | 0.78x | 1.30x | 0.86x | 1.00x | 0.63x | 1.20x | 0.27x | 0.64x | 0.64x | 0.48x | 0.31x | 0.15x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |